Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Drugs & Aging
|
April 9, 2005
Cytochrome p450 polymorphisms in geriatric patients: impact on adverse drug reactions--a pilot study
Tobias Egger, Harald Dormann, Gabi Ahne, et al.
The Journal of Clinical Investigation
|
February 19, 2005
Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype
Heiko Reinold, Seifollah Ahmadi, Ulrike B Depner, et al.
European Journal of Clinical Pharmacology
|
December 18, 2007
The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients
Charalampos Dragonas, Jan T Wagner, Hans J Heppner, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
May 31, 2021
Design, Synthesis, and Biochemical Evaluation of Alpha-Amanitin Derivatives Containing Analogs of the trans-Hydroxyproline Residue for Potential Use in Antibody-Drug Conjugates
Kaveh Matinkhoo, Antonio A W L Wong, Chido M Hambira, et al.
Journal of the American Chemical Society
|
August 30, 2021
Iodine-Mediated Tryptathionine Formation Facilitates the Synthesis of Amanitins
Guiyang Yao, Caroline H Knittel, Simone Kosol, et al.
Journal of the American College of Cardiology
|
May 17, 2008
Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents
Dietmar Trenk, Willibald Hochholzer, Martin F Fromm, et al.
Science Translational Medicine
|
February 11, 2021
Targeted immunotherapy for HER2-low breast cancer with 17p loss
Yujing Li, Yifan Sun, Michael Kulke, et al.
Blood
|
August 1, 2022
Anti-CD37 α-amanitin-conjugated antibodies as potential therapeutic weapons for Richter syndrome
Tiziana Vaisitti, Nicoletta Vitale, Matilde Micillo, et al.
Molecular Cancer Therapeutics
|
December 10, 2020
HDP-101, an Anti-BCMA Antibody-Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells
Vianihuini Figueroa-Vazquez, Jonathan Ko, Christian Breunig, et al.
Research Square
|
January 23, 2024
Novel Anti-B-cell Maturation Antigen Alpha-Amanitin Antibody-drug Conjugate HDP-101 Shows Superior Activity to Belantamab Mafodotin and Enhanced Efficacy in Deletion 17p Myeloma Models
Ram Kumar Singh, Richard J Jones, Fazal Shirazi, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Drugs & Aging
|
April 9, 2005
Cytochrome p450 polymorphisms in geriatric patients: impact on adverse drug reactions--a pilot study
Tobias Egger, Harald Dormann, Gabi Ahne, et al.
The Journal of Clinical Investigation
|
February 19, 2005
Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype
Heiko Reinold, Seifollah Ahmadi, Ulrike B Depner, et al.
European Journal of Clinical Pharmacology
|
December 18, 2007
The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients
Charalampos Dragonas, Jan T Wagner, Hans J Heppner, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
May 31, 2021
Design, Synthesis, and Biochemical Evaluation of Alpha-Amanitin Derivatives Containing Analogs of the trans-Hydroxyproline Residue for Potential Use in Antibody-Drug Conjugates
Kaveh Matinkhoo, Antonio A W L Wong, Chido M Hambira, et al.
Journal of the American Chemical Society
|
August 30, 2021
Iodine-Mediated Tryptathionine Formation Facilitates the Synthesis of Amanitins
Guiyang Yao, Caroline H Knittel, Simone Kosol, et al.
Journal of the American College of Cardiology
|
May 17, 2008
Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents
Dietmar Trenk, Willibald Hochholzer, Martin F Fromm, et al.
Science Translational Medicine
|
February 11, 2021
Targeted immunotherapy for HER2-low breast cancer with 17p loss
Yujing Li, Yifan Sun, Michael Kulke, et al.
Blood
|
August 1, 2022
Anti-CD37 α-amanitin-conjugated antibodies as potential therapeutic weapons for Richter syndrome
Tiziana Vaisitti, Nicoletta Vitale, Matilde Micillo, et al.
Molecular Cancer Therapeutics
|
December 10, 2020
HDP-101, an Anti-BCMA Antibody-Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells
Vianihuini Figueroa-Vazquez, Jonathan Ko, Christian Breunig, et al.
Research Square
|
January 23, 2024
Novel Anti-B-cell Maturation Antigen Alpha-Amanitin Antibody-drug Conjugate HDP-101 Shows Superior Activity to Belantamab Mafodotin and Enhanced Efficacy in Deletion 17p Myeloma Models
Ram Kumar Singh, Richard J Jones, Fazal Shirazi, et al.
Page
of 6